Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_assertion type Assertion NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_head.
- NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_assertion wasGeneratedBy ECO_0000203 NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_provenance.
- NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_assertion wasDerivedFrom befree-2016 NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_provenance.
- NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_assertion SIO_000772 21249428 NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_provenance.
- NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_assertion evidence source_evidence_literature NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_provenance.
- NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_assertion description "[While SOCS-3 mRNA levels increased, plasma TNFα and IL-6 levels were also significantly higher in patients with type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866543.RAGHC9DfW-3twtc9e46G6xvwgfpfDxLQLhWLp_GVlNghY130_provenance.